Home › Research › What the research found › Every row
Every row of the evidence table
One row per finding: what was tested, which way the result went, and how the study was built. The answer by area, and where the studies disagree, are on the main page.
Every row
Filter
Showing 3 of 382 rows for Omega-3 / fish and fish oil. One row per study per exposure: a study that tested two different things appears twice, once for each.
Scroll the table sideways to see every column.
| Exposure | Question | Direction | Outcome measured | Design | People | Effect size, as the source reported it | Source |
|---|---|---|---|---|---|---|---|
| Omega-3 / fish and fish oil Diet and supplements | Prevention |
No effect
whyRisk ratios close to one across every intake strategy, including substituting fish for meat. This is the one study here that emulates a trial rather than comparing eaters with non-eaters, and it disagrees with the pooled cohorts. |
21-year Alzheimer's disease risk | cohort study | 2,012 | 21-year Alzheimer's risk 10.33% (no fish) vs 9.98% (3+ servings/week); risk ratios near 1 |
American Journal of Epidemiology
2026 ✓ Peer-reviewed PMID 42506897 |
| Omega-3 / fish and fish oil Diet and supplements | Prevention |
Mixed
whyThe biochemical primary outcome was met (DHA raised the CSF DHA-to-arachidonic-acid ratio versus placebo), but there was no difference in cognition or brain volume over 24 months. The authors recommend against further supplementation trials of this kind. |
CSF DHA/AA ratio at 6 months (primary, target engagement); cognition and brain volumes at 24 months | phase 2 trial | 365 | DHA supplementation increased CSF DHA/AA ratio at 6 months vs placebo (0.17 [95% CI 0.15-0.18] vs -0.02 [95% CI -0.04 to -0.0004]; difference 0.19 [95% CI 0.16-0.21]; p < 0.0001), independent of APOE ε4 status (interaction p = 0.71). Dropout was 38%, mainly due to COVID-19. No treatment differences were observed in brain volumes or cognitive performance over 24 months |
EBioMedicine
2026 ✓ Peer-reviewed PMID 42315445 |
| Omega-3 / fish and fish oil Diet and supplements | Prevention |
Benefit
whyDietary intake and blood levels, pooled from observational cohorts. The much larger supplement estimate (HR 0.36) comes from one cohort's self-selected supplement users, not from a trial. |
All-cause dementia or cognitive decline | meta-analysis | 103,651 | Dietary DHA intake RR 0.82 for dementia or cognitive decline; ADNI supplement users HR 0.36 (95% CI 0.18-0.72) for Alzheimer's |
American Journal of Clinical Nutrition
2023 ✓ Peer-reviewed PMID 37028557 |
Last updated